Implanet S.A. (EPA:ALIMP)
France
· Delayed Price · Currency is EUR 0.220
-0.004 (-1.79%)
At close: Mar 6, 2026
Implanet Revenue
Implanet had revenue of 5.81M EUR in the half year ending June 30, 2025, with 36.11% growth. This brings the company's revenue in the last twelve months to 11.10M, up 52.11% year-over-year. In the year 2024, Implanet had annual revenue of 9.41M with 26.31% growth.
Revenue (ttm)
11.10M
Revenue Growth
+52.11%
P/S Ratio
2.49
Revenue / Employee
241.26K
Employees
46
Market Cap
27.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.41M | 1.96M | 26.31% |
| Dec 31, 2023 | 7.45M | -581.00K | -7.24% |
| Dec 31, 2022 | 8.03M | 1.89M | 30.75% |
| Dec 31, 2021 | 6.14M | 2.25M | 57.76% |
| Dec 31, 2020 | 3.89M | -3.52M | -47.46% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Theraclion | 1.87M |
| Novacyt | 22.69M |
| Ikonisys | 1.47M |
| Diagnostic Medical Systems | 49.47M |
| Mauna Kea Technologies | 8.18M |
| Biosynex | 97.95M |
| SpineGuard | 4.32M |
| Bluelinea Société Anonyme | 11.68M |
Implanet News
- 7 weeks ago - Implanet S.A. reports FY results - Seeking Alpha
- 5 months ago - Implanet S.A. reports Q3 results - Seeking Alpha